BACKGROUND Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant cancer susceptibility genes. Underlying genetic heterogeneity, as well as the high sporadic background of the disease, has resulted in many signals that are often not reproducible between research studies. METHODS We conducted a SNP-based genome wide linkage scan on 131 Caucasian prostate cancer families participating in the University of Michigan Prostate Cancer Genetics Project (PCGP). RESULTS The strongest evidence for linkage was detected at 16q23 (LOD = 2.70 at rs1079635). Prostate cancer linkage to the same region of 16q23 has been observed by others and the region contains several strong candidate genes including the known ...
Background and aims: Prostate cancer is the leading cancer type in Finnish men. It was suggested tha...
Genome-wide association study–identified prostate cancer risk variants explain only a relatively sma...
Family history is a significant risk factor for prostate cancer, although the molecular basis for th...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Epidemiological and twin studies have consistently demonstrated a strong genetic component to prosta...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Prostate cancer represents a significant worldwide public health burden. Epidemiological and genetic...
Background Prostate cancer (PC) is generally believed to have a strong inherited component, but the ...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
BACKGROUND Prostate cancer (PC) is generally believed to have a strong inherited component, but the...
Background and aims: Prostate cancer is the leading cancer type in Finnish men. It was suggested tha...
Family history is a significant risk factor for prostate cancer, although the molecular basis for th...
Background and aims: Prostate cancer is the leading cancer type in Finnish men. It was suggested tha...
Genome-wide association study–identified prostate cancer risk variants explain only a relatively sma...
Family history is a significant risk factor for prostate cancer, although the molecular basis for th...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Epidemiological and twin studies have consistently demonstrated a strong genetic component to prosta...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Prostate cancer represents a significant worldwide public health burden. Epidemiological and genetic...
Background Prostate cancer (PC) is generally believed to have a strong inherited component, but the ...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
BACKGROUND Prostate cancer (PC) is generally believed to have a strong inherited component, but the...
Background and aims: Prostate cancer is the leading cancer type in Finnish men. It was suggested tha...
Family history is a significant risk factor for prostate cancer, although the molecular basis for th...
Background and aims: Prostate cancer is the leading cancer type in Finnish men. It was suggested tha...
Genome-wide association study–identified prostate cancer risk variants explain only a relatively sma...
Family history is a significant risk factor for prostate cancer, although the molecular basis for th...